Associations of Sociodemographic and Clinical Factors with Late Presentation for Early Infant HIV Diagnosis (EID) Services in Kenya

Authors

  • Agnes Langat, MMed Division of Global HIV & TB., Center for Global Health, U.S Centers for Disease Control and Prevention (CDC), P.O. Box 606- 00202 Nairobi, Kenya; Center for International Health, University of Bergen, P.O. Box 7800 5020 Bergen, Norway
  • Tegan L. Callahan, MPH Division of Global HIV & TB., Center for Global Health, U.S Centers for Disease Control and Prevention (CDC), Atlanta, USA
  • Isabella Yonga, BDS Health Population and Nutrition Office, USAID, P.O. Box 629, Village Market 00621 Nairobi, Kenya
  • Boniface Ochanda, CO Division of Global HIV & TB., Center for Global Health, U.S Centers for Disease Control and Prevention (CDC), P.O. Box 606- 00202 Nairobi, Kenya
  • Anthony Waruru, PhD Division of Global HIV & TB., Center for Global Health, U.S Centers for Disease Control and Prevention (CDC), P.O. Box 606- 00202 Nairobi, Kenya
  • Lucy W. Ng’anga, MMed Division of Global HIV & TB., Center for Global Health, U.S Centers for Disease Control and Prevention (CDC), P.O. Box 606- 00202 Nairobi, Kenya
  • Abraham Katana, MD Division of Global HIV & TB., Center for Global Health, U.S Centers for Disease Control and Prevention (CDC), P.O. Box 606- 00202 Nairobi, Kenya
  • Brian Onyango, MSc Health Population and Nutrition Office, USAID, P.O. Box 629, Village Market 00621 Nairobi, Kenya
  • Benson Singa, MPH Kenya Medical Research Institute (KEMRI), P.O. Box 20778- 00202 Nairobi, Kenya
  • Stephen Oyule, MPH The US. Military HIV Research Program (MHRP), P.O. Box 54-40100 Kisumu, Kenya
  • George Githuka, MSc National AIDS and STI Control Program (NASCOP), Ministry of Health. P.O. Box 19361-00202 Nairobi, Kenya
  • Lennah Omoto, MMed Division of Global HIV & TB., Center for Global Health, U.S Centers for Disease Control and Prevention (CDC), P.O. Box 606- 00202 Nairobi, Kenya
  • Jane Muli, MPH The US. Military HIV Research Program (MHRP), P.O. Box 54-40100 Kisumu, Kenya
  • Thorkild Tylleskar, PhD Center for International Health, University of Bergen, P.O. Box 7800 5020 Bergen, Norway
  • Surbhi Modi, MD Division of Global HIV & TB., Center for Global Health, U.S Centers for Disease Control and Prevention (CDC), Atlanta, USA

DOI:

https://doi.org/10.21106/ijma.537

Keywords:

Antenatal Care , EID , HIV , Early Infant Testing , PMTCT , Antiretroviral Treatment , Kenya

Abstract

Background: Understanding the missed opportunities in early infant HIV testing within the PMTCT program is essential to address any gaps. The study set out to describe the clinical and sociodemographic characteristics of the infants presenting late for early infant diagnosis in Kenya.

Methods: We abstracted routinely collected clinical and sociodemographic characteristics, in a cross-sectional study, on all HIV-infected infants with a positive polymerase chain reaction (PCR) test from 1,346 President’s Emergency Plan for AIDS Relief (PEPFAR) supported health facilities for the period October 2016 to September 2018. We used multivariate logistic regression to examine the association of sociodemographic and clinical characteristics with late (>2 months after birth) presentation for infant HIV testing.

Results: Of the 4,011 HIV-infected infants identified, the median infant age at HIV diagnosis was 3 months [interquartile range (IQR), 1-16 months], and two-thirds [2,669 (66.5%)] presented late for infant HIV testing. Factors that were associated with late presentation for infant testing were: maternal ANC non-attendance, adjusted odds ratio (aOR) 1.41 (95% confidence interval (CI) 1.18 -1.69); new maternal HIV diagnosis, aOR 1.45, (95%CI 1.24 -1.7); and lack of maternal antiretroviral therapy(ART), aOR 1.94, (95% CI 1.64 - 2.30). There was a high likelihood of identifying HIV-infected infants among infants who presented for medical services in the outpatient setting (aOR 18.9; 95% CI 10.2 - 34.9) and inpatient setting (aOR 12.2; 95% CI 6.23-23.9) compared to the infants who presented late in maternity.

Conclusion and Global Health Implications: Gaps in early infant HIV testing suggest the need to increase maternal pre-pregnancy HIV diagnosis, timely antenatal care, early infant diagnosis services, early identification of mothers who seroconvert during pregnancy or breastfeeding and improved HIV screening in outpatient and inpatient settings. Early referral from the community and access to health facilities should be strengthened by the implementation of national PMTCT guidelines.

 

Copyright © 2021 Langat et al. Published by Global Health and Education Projects, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution License CC BY 4.0.

Downloads

Download data is not yet available.

Downloads

Publication History

Issue

Section

Original Article

License